Site Map | Legal Policy | Privacy Policy

 

SEC Documents

  
Filing Description Date Filed Sorted Descending Size  
10-Q quarterly report May 8, 2008 448.1 KB  
8-K current report May 1, 2008 64.0 KB  
DEF 14A definitive proxy statement Apr 29, 2008 326.8 KB  
8-K current report Apr 7, 2008 33.7 KB  
10-K annual report Mar 5, 2008 1.1 MB  
8-K current report Feb 20, 2008 63.8 KB  
SC 13G/A amended statement of beneficial ownership Feb 14, 2008 34.2 KB  
SC 13G/A amended statement of beneficial ownership Feb 14, 2008 40.6 KB  
SC 13G statement of beneficial ownership Feb 14, 2008 25.4 KB  
SC 13G/A amended statement of beneficial ownership Feb 14, 2008 29.5 KB  
SC 13G/A amended statement of beneficial ownership Feb 14, 2008 43.3 KB  
SC 13G statement of beneficial ownership Feb 11, 2008 29.4 KB  
SC 13G statement of beneficial ownership Feb 11, 2008 36.4 KB  
SC 13G/A amended statement of beneficial ownership Jan 23, 2008 18.2 KB  
8-K current report Dec 26, 2007 19.8 KB  
8-K current report Dec 19, 2007 320.5 KB  
8-K current report Dec 12, 2007 26.1 KB  
8-K current report Dec 6, 2007 36.0 KB  
10-Q quarterly report Nov 8, 2007 740.1 KB  
8-K current report Nov 8, 2007 51.3 KB  
Showing 1-20 of 378 Page: 1 2 3 ... 19  Next 20
News

Ligand Pharmaceuticals Announces First Quarter Results

Ligand Initiates Phase II Trial with LGD-4665 in Idiopathic .......

Upcoming Events

Q1 2008 Ligand Pharmaceuticals Incorporated Earnings Confere...

Susquehanna Financial Group Second Annual SIGnificant Option...

Q4 2007 Ligand Pharmaceuticals Incorporated Earnings Confere...

Investor Relations|News|Presentations & Events|SEC Documents|
Corporate Governance|Email Alerts
LGND - (NASD)
$3.39   - 0.03